Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Pertussis surveillance by small serosurveys of blood donors.

Kennerknecht N, Riffelmann M, Voelker U, Wirsing von König CH.

Epidemiol Infect. 2018 Oct;146(14):1807-1810. doi: 10.1017/S0950268818001851. Epub 2018 Jul 10.

PMID:
29986784
2.

Controlling pertussis: how can we do it? A focus on immunization.

Martinón-Torres F, Heininger U, Thomson A, Wirsing von König CH.

Expert Rev Vaccines. 2018 Apr;17(4):289-297. doi: 10.1080/14760584.2018.1445530. Epub 2018 Mar 12. Review.

PMID:
29482390
3.

Erratum for Carbonetti et al., "Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development".

Carbonetti NH, Wirsing von König CH, Lan R, Jacob-Dubuisson F, Cotter PA, Deora R, Merkel TJ, van Els CA, Locht C, Hozbor D, Rodriguez ME.

Clin Vaccine Immunol. 2017 May 5;24(5). pii: e00071-17. doi: 10.1128/CVI.00071-17. Print 2017 May. No abstract available.

4.

Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development.

Carbonetti NH, Wirsing von König CH, Lan R, Jacob-Dubuisson F, Cotter PA, Deora R, Merkel TJ, van Els CA, Locht C, Hozbor D, Rodriguez ME.

Clin Vaccine Immunol. 2016 Nov 4;23(11):842-850. Print 2016 Nov. Erratum in: Clin Vaccine Immunol. 2017 May 5;24(5):.

5.

Surveillance of pertussis: methods and implementation.

Guiso N, Wirsing von König CH.

Expert Rev Anti Infect Ther. 2016 Jul;14(7):657-67. doi: 10.1080/14787210.2016.1190272. Epub 2016 May 31. Review.

PMID:
27224518
6.

Latent class analysis of diagnostic tests for adenovirus, Bordetella pertussis and influenza virus infections in German adults with longer lasting coughs.

Sobotzki C, Riffelmann M, Kennerknecht N, Hülsse C, Littmann M, White A, Von Kries R, Wirsing VON König CH.

Epidemiol Infect. 2016 Mar;144(4):840-6. doi: 10.1017/S0950268815002149. Epub 2015 Sep 18.

PMID:
26380914
7.

Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013.

Tan T, Dalby T, Forsyth K, Halperin SA, Heininger U, Hozbor D, Plotkin S, Ulloa-Gutierrez R, Wirsing von König CH.

Pediatr Infect Dis J. 2015 Sep;34(9):e222-32. doi: 10.1097/INF.0000000000000795. Review.

PMID:
26376316
8.

Strategies to decrease pertussis transmission to infants.

Forsyth K, Plotkin S, Tan T, Wirsing von König CH.

Pediatrics. 2015 Jun;135(6):e1475-82. doi: 10.1542/peds.2014-3925. Epub 2015 May 11. Review.

9.

Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.

van Gent M, Heuvelman CJ, van der Heide HG, Hallander HO, Advani A, Guiso N, Wirsing von Kőnig CH, Vestrheim DF, Dalby T, Fry NK, Pierard D, Detemmerman L, Zavadilova J, Fabianova K, Logan C, Habington A, Byrne M, Lutyńska A, Mosiej E, Pelaz C, Gröndahl-Yli-Hannuksela K, Barkoff AM, Mertsola J, Economopoulou A, He Q, Mooi FR.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):821-30. doi: 10.1007/s10096-014-2297-2. Epub 2014 Dec 20.

10.

Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012.

Zeddeman A, van Gent M, Heuvelman CJ, van der Heide HG, Bart MJ, Advani A, Hallander HO, Wirsing von Konig CH, Riffelman M, Storsaeter J, Vestrheim DF, Dalby T, Krogfelt KA, Fry NK, Barkoff AM, Mertsola J, He Q, Mooi F.

Euro Surveill. 2014 Aug 21;19(33). pii: 20881.

11.

Pertussis diagnostics: overview and impact of immunization.

Wirsing von König CH.

Expert Rev Vaccines. 2014 Oct;13(10):1167-74. doi: 10.1586/14760584.2014.950237. Epub 2014 Aug 21. Review.

PMID:
25142439
12.

External quality assessment of pertussis serology in Germany.

Riffelmann M, Hunfeld KP, Müller I, Xing D, Kennerknecht N, Wirsing von König CH.

Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):421-3. doi: 10.1007/s10096-012-1759-7. Epub 2012 Oct 19.

PMID:
23076769
13.

Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011.

Cherry JD, Tan T, Wirsing von König CH, Forsyth KD, Thisyakorn U, Greenberg D, Johnson D, Marchant C, Plotkin S.

Clin Infect Dis. 2012 Jun;54(12):1756-64. doi: 10.1093/cid/cis302. Epub 2012 Mar 19.

14.

Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.

von Kries R, Weiss S, Falkenhorst G, Wirth S, Kaiser P, Huppertz HI, Tenenbaum T, Schroten H, Streng A, Liese J, Shai S, Niehues T, Girschick H, Kuscher E, Sauerbrey A, Peters J, Wirsing von König CH, Rückinger S, Hampl W, Michel D, Mertens T.

PLoS One. 2011;6(9):e23955. doi: 10.1371/journal.pone.0023955. Epub 2011 Sep 7.

15.

Comparison of commercially available immunoblot assays measuring IgG and IgA antibodies to Bordetella pertussis antigens.

Kennerknecht N, Riffelmann M, Schmetz J, Wirsing von König CH.

Eur J Clin Microbiol Infect Dis. 2011 Dec;30(12):1531-5. doi: 10.1007/s10096-011-1256-4. Epub 2011 Apr 20.

PMID:
21503838
16.

The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010.

Guiso N, Wirsing von König CH, Forsyth K, Tan T, Plotkin SA.

Vaccine. 2011 Feb 1;29(6):1115-21. doi: 10.1016/j.vaccine.2010.12.010. Epub 2010 Dec 17.

PMID:
21168525
17.

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories.

Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH; EU Pertstrain group.

Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):307-12. doi: 10.1007/s10096-010-1104-y. Epub 2010 Nov 11. Review.

18.

Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measures.

Walther-Wenke G, Wirsing von König CH, Däubener W, Heiden M, Hoch J, Hornei B, Volkers P; Working Party on Bacteria Safety in Transfusion Medicine, Advisory Board of the German Ministry of Health, Berlin.

Vox Sang. 2011 May;100(4):359-66. doi: 10.1111/j.1423-0410.2010.01432.x. Epub 2010 Oct 28.

PMID:
21029110
19.

The global pertussis initiative: Meeting report from the Regional Latin America Meeting, Costa Rica, 5-6 December, 2008.

Ulloa-Gutierrez R, Hozbor D, Avila-Aguero ML, Caro J, Wirsing von König CH, Tan T, Plotkin S.

Hum Vaccin. 2010 Nov;6(11):876-80. Epub 2010 Nov 1.

PMID:
20980794
20.

Pertussis: not only a disease of childhood.

Riffelmann M, Littmann M, Hülße C, Hellenbrand W, Wirsing von König CH.

Dtsch Arztebl Int. 2008 Sep;105(37):623-8. doi: 10.3238/arztebl.2008.0623. Epub 2008 Sep 12.

21.

[Lifelong protection against pertussis].

Riffelmann M, Wirsing von König CH.

Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S86-9. doi: 10.1055/s-0029-1220216. Epub 2009 Apr 7. German.

PMID:
19353478
22.

The epidemiology of pertussis in Germany: past and present.

Hellenbrand W, Beier D, Jensen E, Littmann M, Meyer C, Oppermann H, Wirsing von König CH, Reiter S.

BMC Infect Dis. 2009 Feb 25;9:22. doi: 10.1186/1471-2334-9-22.

23.

Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.

Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, Gaines-Das R.

Clin Vaccine Immunol. 2009 Mar;16(3):303-11. doi: 10.1128/CVI.00372-08. Epub 2008 Dec 24.

24.

International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007.

Tondella ML, Carlone GM, Messonnier N, Quinn CP, Meade BD, Burns DL, Cherry JD, Guiso N, Hewlett EL, Edwards KM, Xing D, Giammanco A, Wirsing von König CH, Han L, Hueston L, Robbins JB, Powell M, Mink CM, Poolman JT, Hildreth SW, Lynn F, Morris A.

Vaccine. 2009 Feb 5;27(6):803-14. doi: 10.1016/j.vaccine.2008.11.072. Epub 2008 Dec 9.

PMID:
19071179
25.

Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination.

Rieber N, Graf A, Belohradsky BH, Hartl D, Urschel S, Riffelmann M, Wirsing von König CH, Liese J.

Vaccine. 2008 Dec 9;26(52):6929-35. doi: 10.1016/j.vaccine.2008.09.064. Epub 2008 Oct 11.

PMID:
18852002
26.

Cost-effectiveness of adult pertussis vaccination in Germany.

Lee GM, Riffelmann M, Wirsing von Konig CH.

Vaccine. 2008 Jul 4;26(29-30):3673-9. doi: 10.1016/j.vaccine.2008.04.068. Epub 2008 May 19.

PMID:
18538901
27.

Long-term immunogenicity of a single dose of acellular pertussis vaccine in paediatric health-care workers.

Littmann M, Hülsse C, Riffelmann M, Wirsing von König CH.

Vaccine. 2008 May 2;26(19):2344-9. doi: 10.1016/j.vaccine.2008.02.065. Epub 2008 Mar 19.

PMID:
18396360
28.

Measuring immunoglobulin g antibodies to tetanus toxin, diphtheria toxin, and pertussis toxin with single-antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay.

Reder S, Riffelmann M, Becker C, Wirsing von König CH.

Clin Vaccine Immunol. 2008 May;15(5):744-9. doi: 10.1128/CVI.00225-07. Epub 2008 Mar 5.

29.

Hepatitis E Virus.

Pauli G, Blümel J, Burger R, Drosten C, Gröner A, Gürtler L, Heiden M, Hildebrandt M, Jansen B, Klamm H, Montag-Lessing T, Offergeld R, Seitz R, Schlenkrich U, Schottstedt V, Willkommen H, Wirsing von König CH.

Transfus Med Hemother. 2008;35(1):50-57. Epub 2008 Jan 18. No abstract available.

30.

Pertussis: an old disease in new clothes.

Wirsing von König CH, Riffelman M.

Euro Surveill. 2007 Sep 1;12(9):E1-2. No abstract available.

PMID:
17991412
31.

Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting.

Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S.

Vaccine. 2007 Mar 30;25(14):2634-42. Epub 2006 Dec 22.

PMID:
17280745
32.

[Pertussis: incidence, symptoms and costs].

Riffelmann M, Littmann M, Hülsse C, O'Brien J, Wirsing von König CH.

Dtsch Med Wochenschr. 2006 Dec 15;131(50):2829-34. German.

PMID:
17160764
33.

Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population.

Knuf M, Zepp F, Meyer C, Grzegowski E, Wolter J, Riffelmann M, Wirsing von König CH.

Vaccine. 2006 Mar 15;24(12):2043-8. Epub 2005 Nov 28.

PMID:
16356597
34.

Nucleic Acid amplification tests for diagnosis of Bordetella infections.

Riffelmann M, Wirsing von König CH, Caro V, Guiso N; Pertussis PCR Consesus Group.

J Clin Microbiol. 2005 Oct;43(10):4925-9. Review. No abstract available.

35.

Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations.

Wirsing von König CH, Campins-Marti M, Finn A, Guiso N, Mertsola J, Liese J.

Pediatr Infect Dis J. 2005 May;24(5 Suppl):S87-92. Review.

PMID:
15876934
36.

[Anthrax. Basic principles and preventive measures].

Maiwald-Schirra C, Riffelmann M, Wirsing von König CH.

Kinderkrankenschwester. 2001 Dec;20(12):511-4. German. No abstract available.

PMID:
14584137
37.

Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany.

Juretzko P, von Kries R, Hermann M, Wirsing von König CH, Weil J, Giani G.

Clin Infect Dis. 2002 Jul 15;35(2):162-7. Epub 2002 Jun 19.

PMID:
12087522
38.

Molecular diagnosis of analbuminemia: a novel mutation identified in two Amerindian and two Turkish families.

Galliano M, Campagnoli M, Rossi A, Wirsing von König CH, Lyon AW, Cefle K, Yildiz A, Palanduz S, Ozturk S, Minchiotti L.

Clin Chem. 2002 Jun;48(6 Pt 1):844-9.

39.

Real-time LightCycler PCR for detection and discrimination of Bordetella pertussis and Bordetella parapertussis.

Kösters K, Reischl U, Schmetz J, Riffelmann M, Wirsing von König CH.

J Clin Microbiol. 2002 May;40(5):1719-22.

40.

Stability of antibodies to Bordetella antigens in German adults.

Saemann-Ischenko G, Tillmanns B, Kösters K, Riffelmann M, Wirsing von König CH.

Eur J Clin Microbiol Infect Dis. 2001 Dec;20(12):850-3.

PMID:
11837635
41.

Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration.

Campins-Martí M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM, Mertsola J, Oselka G, Ward J, Wirsing von König CH, Zepp F; International Consensus Group on Pertussis Immunisation.

Vaccine. 2001 Dec 12;20(5-6):641-6. Review.

PMID:
11738728
42.

[Pertussis in adults: symptoms, epidemiology and prevention].

Lugauer S, Stehr K, Wirsing von König CH, Heininger U.

Dtsch Med Wochenschr. 2001 Nov 9;126(45):1272-7. Review. German. No abstract available.

PMID:
11700569
43.

Pertussis in Germany: regional differences in management and vaccination status of hospitalized cases.

Juretzko P, Fabian-Marx T, Haastert B, Giani G, von Kries R, Wirsing von König CH.

Epidemiol Infect. 2001 Aug;127(1):63-71.

44.

Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples.

Kösters K, Riffelmann M, Wirsing von König CH.

J Med Microbiol. 2001 May;50(5):436-40.

PMID:
11339251
45.

Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology.

Mooi FR, Hallander H, Wirsing von König CH, Hoet B, Guiso N.

Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):174-81.

PMID:
10795589
46.

[Travel vaccinations for children].

Wirsing von König CH, Riffelmann M.

Kinderkrankenschwester. 1999 Aug;18(8):322-6. German. No abstract available.

PMID:
10531945
47.

Observer bias in acellular pertussis vaccine trials.

Wirsing von König CH, Schmitt HJ, Neiss A.

Pediatrics. 1999 Sep;104(3 Pt 1):577-8. No abstract available.

PMID:
10515769
48.

Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children.

Wirsing von König CH, Gounis D, Laukamp S, Bogaerts H, Schmitt HJ.

Eur J Clin Microbiol Infect Dis. 1999 May;18(5):341-5.

PMID:
10421041
49.

[Illustrations of nosocomial pediatric infections].

Wirsing von König CH, Ritter E.

Kinderkrankenschwester. 1998 Aug;17(8):333-6. German. No abstract available.

PMID:
9748946
50.

Pertussis complications in Germany--3 years of hospital-based surveillance during the introduction of acellular vaccines.

Herzig P, Hartmann C, Fischer D, Weil J, von Kries R, Giani G, Schroten H, Wirsing von König CH.

Infection. 1998 Jul-Aug;26(4):227-31.

PMID:
9717680

Supplemental Content

Loading ...
Support Center